首页> 外文期刊>QJM: Monthly journal of the Association of Physicians >Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia
【24h】

Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia

机译:Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia

获取原文
获取原文并翻译 | 示例
       

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号